ARS Pharmaceuticals, Inc.
HealthcareNASDAQ:SPRY · NASDAQ Global Market
+$0.17 today
Vol 1.32M · Avg 1.71M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-36.58%
Period High
$18.35
Period Low
$6.73
Latest
$9.76
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Nanobiotix S.A.
NASDAQ:NBTX
$1.80B
Tyra Biosciences, Inc.
NASDAQ:TYRA
$1.61B
GH Research PLC
NASDAQ:GHRS
$1.45B
Palvella Therapeutics, Inc.
NASDAQ:PVLA
$1.29B
Savara Inc.
NASDAQ:SVRA
$1.08B
Arbutus Biopharma Corporation
NASDAQ:ABUS
$841.51M
Kura Oncology, Inc.
NASDAQ:KURA
$803.41M
Rezolute, Inc.
NASDAQ:RZLT
$385.17M
ProKidney Corp.
NASDAQ:PROK
$242.99M
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$212.27M
What is the latest SPRY filing?
The latest filing shown is 3 dated Jun 1, 2026.
How many recent filings does SPRY have?
Intrinsic Alpha currently shows 20 recent filings for SPRY.
Explore More
Continue the stock analysis
Jump to another research area for this company.